People · Operator
Named in public records as an officer, director or promoter · active 2012–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aerie Pharmaceuticals Inc | — | Biotechnology | Series D+ | $189.6M | $5.2B | 2014 |
| Graybug Vision, Inc. | — | Biotechnology | Series C | $144.8M | $132.4M | 2014 |
| Nacuity Pharmaceuticals, Inc. | — | Biotechnology | Series A | $31.2M | $21.9M | 2021 |
| Aldeyra Therapeutics, Inc. | — | Biotechnology | Series A | $24.6M | $361.5M | 2012 |
Gerald Cagle at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gerald Cagle on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Asish Xavier | 1 | 18 |
| Chau Khuong | 1 | 9 |
| Cameron Wheeler | 1 | 9 |
| Robert Ruffolo | 1 | 8 |
| Brian Levy | 1 | 8 |
| ANAND MEHRA | 1 | 7 |
| Todd Brady | 1 | 7 |
| Christy Shaffer | 1 | 6 |
| David Epstein | 1 | 5 |
| DENNIS HENNER | 1 | 5 |
| Jesse I. Treu | 1 | 5 |
| James Mazzo | 1 | 4 |
| Emmett Cunningham | 1 | 4 |
| Ben Bronstein | 1 | 4 |
| Gary Phillips | 1 | 4 |
| Jeffrey Cleland | 1 | 4 |
| Eric W. Roberts | 1 | 4 |
| Christy L. Shaffer | 1 | 3 |
| Todd C. Brady | 1 | 3 |
| Michael Wall | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.